- Filed
- Mar 3, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Feb 26, 2026 | 3.21M sh |
| Shares Diluted | FY 2025 · Dec 31, 2025 | 3.17M sh |
| Shares Diluted restated | FY 2025 · Dec 31, 2024 | 3.08M sh |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$31.51M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$47.96M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $46.3M |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $37.57M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $18.76M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | $61.26M |
| Stockholders Equity | FY 2025 · Dec 31, 2023 | $111.28M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $23.08M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $19.36M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $43.53M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $41.15M |
| Current Assets | FY 2025 · Dec 31, 2025 | $47.76M |
| Current Assets | FY 2025 · Dec 31, 2024 | $78.82M |
| Total Assets | FY 2025 · Dec 31, 2025 | $62.28M |
| Total Assets | FY 2025 · Dec 31, 2024 | $102.41M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$14.35 |
| Eps Diluted restated | FY 2025 · Dec 31, 2024 | −$21.04 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$14.35 |
| Eps Basic restated | FY 2025 · Dec 31, 2024 | −$21.04 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $19.88M |
| Sga Expense | FY 2025 · Dec 31, 2024 | $24.99M |
| Rd Expense | FY 2025 · Dec 31, 2025 | $23.28M |
| Rd Expense | FY 2025 · Dec 31, 2024 | $40.18M |
| Net Income | FY 2025 · Dec 31, 2025 | −$45.52M |
| Net Income | FY 2025 · Dec 31, 2024 | −$64.77M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$49.3M |
| Operating Income | FY 2025 · Dec 31, 2024 | −$70.4M |
| Capex | FY 2025 · Dec 31, 2024 | $34K |